<DOC>
	<DOCNO>NCT00762476</DOCNO>
	<brief_summary>The purpose study evaluate efficacy 3804-250A prevention common cold . The study also evaluate whether 3804-250A prevents rhinovirus infection , virus cause many common cold .</brief_summary>
	<brief_title>Efficacy Trial 3804-250A Prevention Cold Illnesses</brief_title>
	<detailed_description>Rhinovirus infection frequent cause 80 % cold illnesses fall rhinovirus season . While viral upper respiratory infection generally mild self-limited , associate enormous economic burden lose productivity expenditures treatment . Rhinovirus infection frequently associate medical complication substantial morbidity acute otitis medium exacerbation asthma . Marketed treatment option rhinovirus consist primarily symptomatic cold remedy modest effect specific cold symptom . 3804-250A investigation prevention rhinovirus infection interruption person-to-person transmission appear technologically economically feasible . The study randomize , double-blind , Placebo control , multi-site , parallel design clinical trial conduct natural setting . The study conduct 10-week period fall rhinovirus epidemic season . Healthy , normal subject recruit randomly assign AV Lotion Placebo control group . Subjects use assigned test product define schedule record presence cold illness symptom daily . Subjects return study site every week study review clarification study diary entry , review assessment compliance , specimen collection rhinovirus PCR .</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<criteria>healthy normal good general health pregnancy insulin dependent diabetes daily smoker skin disease hands/wrists immunological disorder occupation involve frequent handwash common cold symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>cold , common</keyword>
	<keyword>rhinovirus</keyword>
</DOC>